Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224667 | SCV000280690 | benign | not provided | 2015-05-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000224667 | SCV002233654 | uncertain significance | not provided | 2022-11-22 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 398 of the COX10 protein (p.Arg398His). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COX10 protein function. ClinVar contains an entry for this variant (Variation ID: 235251). This variant has not been reported in the literature in individuals affected with COX10-related conditions. This variant is present in population databases (rs200942884, gnomAD 0.02%). |
Gene |
RCV000224667 | SCV003194929 | uncertain significance | not provided | 2023-01-20 | criteria provided, single submitter | clinical testing | Reported as heterozygous with no second variant identified in an individual with intellectual disability who had a different genetic etiology for the phenotype (Celis et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25758935) |
Ambry Genetics | RCV002516218 | SCV003740232 | uncertain significance | Inborn genetic diseases | 2022-07-29 | criteria provided, single submitter | clinical testing | The c.1193G>A (p.R398H) alteration is located in exon 7 (coding exon 7) of the COX10 gene. This alteration results from a G to A substitution at nucleotide position 1193, causing the arginine (R) at amino acid position 398 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV000224667 | SCV005412664 | uncertain significance | not provided | 2024-05-09 | criteria provided, single submitter | clinical testing | PP3, PM2 |
Fulgent Genetics, |
RCV005008175 | SCV005643755 | uncertain significance | Mitochondrial complex 4 deficiency, nuclear type 3 | 2024-01-22 | criteria provided, single submitter | clinical testing |